Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients

Clinical Science

Volumn 125, Issue 8, 2013, Pages 391-400

  Kahraman, Alisan ^a   Sowa, Jan Peter ^a   Schlattjan, Martin ^a   Sydor, Svenja ^a   Pronadl, Martin ^b   Wree, Alexander ^a   Beilfuss, Anja ^a   Kilicarslan, Alpaslan ^a,c   Altinbas, Akif ^a   Bechmann, Lars Peter ^a   Syn, Wing Kin ^d   Gerken, Guido ^a   Canbay, Ali ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b ALFRIED KRUPP KRANKENHAUS   (Germany)

^c HACETTEPE UNIVERSITY   (Turkey)

^d Institute of Hepatology   (United Kingdom)

Author keywords

adiponectin; Bariatric surgery; Fetuin A; Non alcoholic fatty liver disease (NAFLD)

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYTOKERATIN 18; FETUIN A; GAMMA GLUTAMYLTRANSFERASE; MESSENGER RNA;

ADULT; ALCOHOLIC FATTY LIVER; APOPTOSIS; ARTICLE; BARIATRIC SURGERY; BODY MASS; CELL DEATH; CELL SURVIVAL; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPID TRANSPORT; LIVER BIOPSY; LIVER CELL; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH BYPASS; WEIGHT REDUCTION; WESTERN BLOTTING;

ADIPONECTIN; ADULT; ALPHA-2-HS-GLYCOPROTEIN; APOPTOSIS; BARIATRIC SURGERY; BLOTTING, WESTERN; BODY MASS INDEX; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACIDS, NONESTERIFIED; FATTY LIVER; FEMALE; GENE EXPRESSION; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-18; LIVER; MALE; OBESITY, MORBID; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS;

EID: 84880171111     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20120542     Document Type: Article

References (42)

1. Shah, K. and Villareal, D. T. (2011) Combination treatment to CONQUER obesity?. Lancet 377, 1295-1297
2. Dowman, J. K., Armstrong, M. J., Tomlinson, J. W. and Newsome, P. N. (2011) Current therapeutic strategies in non-alcoholic fatty liver disease. Diabetes Obes. Metab. 13, 692-702
3. Kushner, R. F. and Noble, C. A. (2006) Long-term outcome of bariatric surgery: an interim analysis. Mayo Clin. Proc. 81, S46-S51
4. Vernon, G., Baranova, A. and Younossi, Z. M. (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment. Pharmacol. Ther. 34, 274-285
5. Ertle, J., Dechêne, A., Sowa, J.-P., Penndorf, V., Herzer, K., Kaiser, G., Schlaak, J. F., Gerken, G., Syn, W.-K. and Canbay, A. (2011) Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. Int. J. Cancer 128, 2436-2443
6. Pulzi, F. B., Cisternas, R., Melo, M. R., Ribeiro, C. M., Malheiros, C. A. and Salles, J. E. (2011) New clinical score to diagnose nonalcoholic steatohepatitis in obese patients. Diabetol. Metab. Syndr. 3, 3
7. Wree, A., Kahraman, A., Gerken, G. and Canbay, A. (2011) Obesity affects the liver - the link between adipocytes and hepatocytes. Digestion 83, 124-133
8. Livhits, M., Mercado, C., Yermilov, I., Parikh, J. A., Dutson, E., Mehran, A., Ko, C. Y. and Gibbons, M. M. (2012) Preoperative predictors of weight loss following bariatric surgery: systematic review. Obes. Surg. 22, 70-89
9. Haukeland, J. W., Dahl, T. B., Yndestad, A., Gladhaug, I. P., Løberg, E. M., Haaland, T., Konopski, Z., Wium, C., Aasheim, E. T., Johansen, O. E. et al. (2012) Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies. Eur. J. Endocrinol. 166, 503-510
10. Hennige, A. M., Staiger, H., Wicke, C., Machicao, F., Fritsche, A., Häring, H.-U. and Stefan, N. (2008) Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS ONE 3, e1765
11. Gastrointestinal Surgery for Severe Obesity (1992) Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am. J. Clin. Nutr. 55, 615S-619S
12. Feldstein, A. E., Wieckowska, A., Lopez, A. R., Liu, Y.-C., Zein, N. N. and McCullough, A. J. (2009) Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology 50, 1072-1078
13. Orci, L., Chilcott, M. and Huber, O. (2011) Short versus long Roux-limb length in Roux-en-Y gastric bypass surgery for the treatment of morbid and super obesity: a systematic review of the literature. Obes. Surg. 21, 797-804
14. Shi, X., Karmali, S., Sharma, A. M. and Birch, D. W. (2010) A review of laparoscopic sleeve gastrectomy for morbid obesity. Obes. Surg. 20, 1171-1177
15. Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y.-C., Torbenson, M. S., Unalp-Arida, A. et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313-1321
16. Kahraman, A., Barreyro, F. J., Bronk, S. F., Werneburg, N. W., Mott, J. L., Akazawa, Y., Masuoka, H. C., Howe, C. L. and Gores, G. J. (2008) TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse. Hepatology 47, 1317-1330
17. Bechmann, L. P., Gieseler, R. K., Sowa, J.-P., Kahraman, A., Erhard, J., Wedemeyer, I., Emons, B., Jochum, C., Feldkamp, T., Gerken, G. et al. (2010) Apoptosis is associated with CD36/fatty acid translocase upregulation in non-alcoholic steatohepatitis. Liver Int. 30, 850-859
18. Alkhouri, N., Carter-Kent, C. and Feldstein, A. E. (2011) Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications. Expert Rev. Gastroenterol. Hepatol. 5, 201-212
19. Kälsch, J., Bechmann, L. P., Kälsch, H., Schlattjan, M., Erhard, J., Gerken, G. and Canbay, A. (2011) Evaluation of biomarkers of NAFLD in a cohort of morbidly obese patients. J. Nutr. Metab. 2011, 369168
20. Kahraman, A., Schlattjan, M., Kocabayoglu, P., Yildiz-Meziletoglu, S., Schlensak, M., Fingas, C. D., Wedemeyer, I., Marquitan, G., Gieseler, R. K., Baba, H. A. et al. (2010) Major histocompatibility complex class I-related chains A and B (MIC A/B): a novel role in nonalcoholic steatohepatitis. Hepatology 51, 92-102
21. Ou, H.-Y., Yang, Y.-C., Wu, H.-T., Wu, J.-S., Lu, F.-H. and Chang, C.-J. (2011) Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes. Clin. Endocrinol. (Oxf.) 75, 450-455
22. Wilfred de Alwis, N. M. and Day, C. P. (2008) Genes and nonalcoholic fatty liver disease. Curr. Diab. Rep. 8, 156-163
23. Jou, J., Choi, S. S. and Diehl, A. M. (2008) Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin. Liver Dis. 28, 370-379
24. Heuer, M., Kaiser, G. M., Kahraman, A., Banysch, M., Saner, F. H., Mathé, Z., Gerken, G., Paul, A., Canbay, A. and Treckmann, J. W. (2012) Liver transplantation in nonalcoholic steatohepatitis is associated with high mortality and post-transplant complications: a single-center experience. Digestion 86, 107-113
25. Burke, A. and Lucey, M. R. (2004) Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. Am. J. Transplant. 4, 686-693
26. Starley, B. Q., Calcagno, C. J. and Harrison, S. A. (2010) Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 51, 1820-1832
27. Gass, M., Beglinger, C. and Peterli, R. (2011) Metabolic surgery-principles and current concepts. Langenbeck's Arch. Surg. 396, 949-972
28. Lazo, M. and Clark, J. M. (2008) The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin. Liver Dis. 28, 339-350
29. Diab, D. L., Yerian, L., Schauer, P., Kashyap, S. R., Lopez, R., Hazen, S. L. and Feldstein, A. E. (2008) Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients. Clin. Gastroenterol. Hepatol. 6, 1249-1254
30. Balistreri, C. R., Caruso, C. and Candore, G. (2010) The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Mediators Inflamm. 2010, 802078
31. Kaser, S., Moschen, A., Cayon, A., Kaser, A., Crespo, J., Pons-Romero, F., Ebenbichler, C. F., Patsch, J. R. and Tilg, H. (2005) Adiponectin and its receptors in non-alcoholic steatohepatitis. Gut 54, 117-121
32. Kamada, Y., Takehara, T. and Hayashi, N. (2008) Adipocytokines and liver disease. J. Gastroenterol. 43, 811-822
33. Moschen, A. R., Molnar, C., Wolf, A. M., Weiss, H., Graziadei, I., Kaser, S., Ebenbichler, C. F., Stadlmann, S., Moser, P. L. and Tilg, H. (2009) Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression. J. Hepatol. 51, 765-777
34. Moschen, A. R., Molnar, C., Enrich, B., Geiger, S., Ebenbichler, C. F. and Tilg, H. (2011) Adipose and liver expression of interleukin (IL)-1 family members in morbid obesity and effects of weight loss. Mol. Med. 17, 840-845
35. Bechmann, L. P., Kocabayoglu, P., Sowa, J.-P., Sydor, S., Best, J., Schlattjan, M., Beilfuss, A., Schmitt, J., Hannivoort, R. A., Rust, C. et al. (2013) Free fatty acids repress SHP activation and adiponectin counteracts bile acid induced liver injury in super-obese patients with NASH. Hepatology 57, 1394- 1406
36. Stefan, N., Hennige, A. M., Staiger, H., Machann, J., Schick, F., Kröber, S. M., Machicao, F., Fritsche, A. and Häring, H.-U. (2006) a2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29, 853-857
37. Reinehr, T. and Roth, C. L. (2008) Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J. Clin. Endocrinol. Metab. 93, 4479-4485
38. Ix, J. H., Shlipak, M. G., Brandenburg, V. M., Ali, S., Ketteler, M. and Whooley, M. A. (2006) Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation 113, 1760-1767
39. Johansson, L., Roos, M., Kullberg, J., Weis, J., Ahlström, H., Sundbom, M., Edén Engström, B. and Karlsson, F. A. (2008) Lipid mobilization following Roux-en-Y gastric bypass examined by magnetic resonance imaging and spectroscopy. Obes. Surg. 18, 1297-1304
40. Löfgren, P., Hoffstedt, J., Rydén, M., Thörne, A., Holm, C., Wahrenberg, H. and Arner, P. (2002) Major gender differences in the lipolytic capacity of abdominal subcutaneous fat cells in obesity observed before and after long-term weight reduction. J. Clin. Endocrinol. Metab. 87, 764-771
41. Pal, D., Dasgupta, S., Kundu, R., Maitra, S., Das, G., Mukhopadhyay, S., Ray, S., Majumdar, S. S. and Bhattacharya, S. (2012) Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat. Med., doi:10.1038/nm.2851
42. Ou, H.-Y., Wu, H.-T., Hung, H.-C., Yang, Y.-C., Wu, J.-S. and Chang, C.-J. (2012) Endoplasmic reticulum stress induces the expression of fetuin-A to develop insulin resistance. Endocrinology 153, 2974-2984